3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Neoplasms
2
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hearing Loss
1
Head and Neck Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Cardiotoxicity
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
8
Tamoxifen
6
Standard of Care
4
Practice Guidelines as Topic
4
Radiotherapy
3
Methods
3
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Radiation
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
ruxolitinib
1
pembrolizumab
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Telemedicine
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Starch
1
Reverse Transcriptase Polymerase Chain Reaction
1
Ranitidine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
Atorvastatin
×
1 year
×
Clear all
No trials found.